BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37036591)

  • 1. Comment on: Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial.
    van de Voort EMF; Franckena M; Struik GM; Moelker A; Klem TMAL
    Ann Surg Oncol; 2023 Jun; 30(6):3284-3285. PubMed ID: 37036591
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial.
    Fine RE; Gilmore RC; Dietz JR; Boolbol SK; Berry MP; Han LK; Kenler AS; Sabel M; Tomkovich KR; VanderWalde NA; Chen M; Columbus KS; Curcio LD; Feldman SM; Gold L; Hernandez L; Manahan ER; Seedman SA; Vaidya RP; Sevrukov AB; Aoun HD; Hicks RD; Simmons RM
    Ann Surg Oncol; 2021 Oct; 28(10):5525-5534. PubMed ID: 34392462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply to: Comment on: Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial.
    Gilmore RC; Fine RE
    Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38839671
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast cancer cryoablation with radiologic-pathologic correlation.
    Pigg N; Gordillo C; Wang Y; Ward RC
    Br J Radiol; 2022 Dec; 95(1140):20220480. PubMed ID: 36000723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipsilateral breast tumor recurrence following breast-conserving surgery for early-stage invasive cancer.
    Fowble B
    Acta Oncol; 1999; 38 Suppl 13():9-17. PubMed ID: 10612491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer: A Pilot Study.
    Khan SY; Melkus MW; Rasha F; Castro M; Chu V; Brandi L; Khan H; Gill HS; Pruitt K; Layeequr Rahman R
    Ann Surg Oncol; 2022 May; 29(5):2914-2925. PubMed ID: 35094188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial.
    Sabel MS; Kaufman CS; Whitworth P; Chang H; Stocks LH; Simmons R; Schultz M
    Ann Surg Oncol; 2004 May; 11(5):542-9. PubMed ID: 15123465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
    Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
    Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryoablation: A promising non-operative therapy for low-risk breast cancer.
    Habrawi Z; Melkus MW; Khan S; Henderson J; Brandi L; Chu V; Layeequr Rahman R
    Am J Surg; 2021 Jan; 221(1):127-133. PubMed ID: 32788081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
    Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
    Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of re-excision and residual disease on local recurrence after breast conservation treatment for patients with early stage breast cancer.
    Ali AN; Vapiwala N; Guo M; Hwang WT; Harris EE; Solin LJ
    Clin Breast Cancer; 2011 Dec; 11(6):400-5. PubMed ID: 21993010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pTis and pT1a Ipsilateral Breast Tumor Recurrence Is Associated with Good Prognosis after Salvage Surgery.
    Ishitobi M; Fukui R; Hashimoto Y; Kittaka N; Nakayama T; Tamaki Y
    Oncology; 2018; 94(1):12-18. PubMed ID: 29017163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes.
    Takada M; Toi M
    Int J Clin Oncol; 2019 Jun; 24(6):608-613. PubMed ID: 30982153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryoablation of Primary Breast Cancer in Patients with Metastatic Disease: Considerations Arising from a Single-Centre Data Analysis.
    Pusceddu C; Melis L; Ballicu N; Meloni P; Sanna V; Porcu A; Fancellu A
    Biomed Res Int; 2017; 2017():3839012. PubMed ID: 29201903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorodeoxyglucose positron emission tomography/computed tomography findings after percutaneous cryoablation of early breast cancer.
    Adachi T; Machida Y; Fukuma E; Tateishi U
    Cancer Imaging; 2020 Jul; 20(1):49. PubMed ID: 32678029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes from ipsilateral breast tumor recurrence after breast conserving surgery and whole breast irradiation for breast cancer.
    Sener SF
    Am J Surg; 2022 Mar; 223(3):445-446. PubMed ID: 34384586
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
    Yi M; Meric-Bernstam F; Kuerer HM; Mittendorf EA; Bedrosian I; Lucci A; Hwang RF; Crow JR; Luo S; Hunt KK
    J Clin Oncol; 2012 Feb; 30(6):600-7. PubMed ID: 22253459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial.
    Arthur DW; Winter KA; Kuerer HM; Haffty B; Cuttino L; Todor DA; Anne PR; Anderson P; Woodward WA; McCormick B; Cheston S; Sahijdak WM; Canaday D; Brown DR; Currey A; Fisher CM; Jagsi R; Moughan J; White JR
    JAMA Oncol; 2020 Jan; 6(1):75-82. PubMed ID: 31750868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflections: The Strengths and Weaknesses of Intraoperative Radiotherapy for Early Breast Cancer and Ipsilateral Tumor Recurrence.
    Sawaki M; Kodaira T; Iwata H
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):660-661. PubMed ID: 31359282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.